Create & localise Veeva CLM Content the Easy Way

Heartbeat™ Veeva CLM

Content Authoring Solution (CAS)

Heartbeat™ Veeva Content Authoring solution by PULSE provides an intuitive, adaptable, and scalable platform that makes it easy for every member of your organisation to create and publish Veeva compliant CLM content. Designed to be used with ease, your teams can create, edit, localise and publish Veeva CLM content in real time with the click of a button.

Heartbeat™ automates your process and lets you concentrate on what’s important- your customers. Heartbeat™ brings together people, process and technology, helping you to create a more efficient and rapid content publishing workflow, empowering your teams to innovate faster and to create engaging Veeva experiences, powered by Veeva, for your customers.

EASY AUTHORING

Create, edit, and update Veeva CLM content in real-time with a simplified content creation process, helping your teams create Veeva compliant content. Works with Veeva CLM, Veeva CRM Approved Email, and Veeva Engage.

ACCELERATE

Accelerate the launch of Veeva content - Heartbeat™ makes it easy for every member of your organisation to create, publish and localise branded, Veeva compliant content, offering a cost-effective and efficient way to create Veeva content.

DRIVE ADOPTION

Drive adoption, adaptation and reuse of global content and assets with local affiliate markets by combining Heartbeat™ Content Authoring Solution with Veeva Modular Content.

LOCALISATION

Increase the adoption of global campaigns with local affiliate markets by simplifying and accelerating the localisation process using automation.

Seamlessly Integrated with Veeva Vault for Complete Content Authoring Control

Heartbeat™- an Accelerator for Veeva CLM Content

Heartbeat™ helps life science companies to keep up with the increased demand for digital content by streamlining content creation, allowing for more time and energy to be spent focusing on customers. With Heartbeat™ your teams can respond to the growing needs and demands of global brand teams to deliver an increasing volume of Veeva CLM content.

Engaging and compliant content can be created across the Veeva Commercial Cloud; Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage Meeting and Veeva Medical CRM.

Designed to be used with ease, artwork assets are automatically converted into HTML code, allowing for simple and convenient content creation. The content creation process is simplified, promoting greater efficiency and allowing for less time and resources to be spent on creating assets. When combined with Veeva Modular Content, MLR reviews are optimised providing one single approval workflow, allowing for accelerated reviews and launches.

Heartbeat™ equips your teams with the tools and capabilities to simplify the creation of compliant assets and accelerate the creation and localisation of Veeva content.

Book a demo

Veeva + Pulse = Better Together

Pulse is the highest certified Veeva Full Service Content Partner in the UK and one of the most accredited in Europe. We have a proven ability to deliver campaigns that utilise Veeva Commercial Cloud.

We help Veeva customers unlock the full potential of Veeva CRM, including Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage Meeting and Veeva Medical CRM. Pulse is your trusted partner, providing hands-on support and expertise to help your organisation drive value and unlock potential.

Other platforms Heartbeat™ integrates with

Get in touch

Schedule a one-on-one meeting and learn more about how Heartbeat™ can work for you

Contact Us

What is Veeva CRM Approved Email? Veeva CRM Approved Email is an email solution built into Veeva CRM which enables pharma organisations to send tailor... [read more]

With in-person events unable to take place during COVID-19 and still limited in many areas, the life sciences industry has shifted to hosting events v... [read more]

Veeva CRM MyInsights helps sales teams to visualise their customer data. Sales teams receive real-time insights delivered directly in Veeva CRM for im... [read more]

Amicus
Bayer
Boehringer Ingelheim
Gsk
Janssen
Johnson and Johnson
Leo
Mayoly Spindler
Mundipharma
Pfizer
Servier
Viiv